NEOPHOTONICS CORP Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Revenue
Cost of goods sold
Gross profit
Operating expenses:
Research and development
Sales and marketing
General and administrative
Amortization of purchased intangible assets
Acquisition and asset sale related costs
Restructuring charges
Litigation settlements
Gain on asset sale
Asset impairment charges
Total operating expenses

Income (loss) from operations
Interest income
Interest expense
Other income (expense), net
Total interest and other income (expense), net
Loss before income taxes
Provision for income taxes
Net loss
Basic net loss per share (USD per share)
Diluted net loss per share (USD per share)
Weighted average shares used to compute basic net loss per share (in shares)
Weighted average shares used to compute diluted net loss per share (in shares)

Comments